An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product
An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product
Enrolling by invitation · NCT07136766 · Registry updated 2025-08-22Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| An 18-week Study to Evaluate a Test Product With a Marketed Prescription Product | Hyperpigmentation, Skin and Connective Tissue Diseases, skin disorder, skin pigmentation disorder | Enrolling by invitation | Phase 3 | 2025-08-22 | NCT07136766 |
2 results · Page 1 of 1
Organizations
Swipe the table sideways for more columns.
| Organizations | Linked trials |
|---|---|
| Good Molecules, LLC | 3 |
| Validated Claim Support | 1 |
1 results · Page 1 of 1
Research sites
Swipe the table sideways for more columns.
| Research sites | City | Country | Linked trials |
|---|---|---|---|
| Validated Claim Support | Teaneck | United States | 1 |